title: [Gynecologic cancer-evidenced based chemotherapy].
abstract: Among gynecologic cancers, ovarian cancer is treated with chemotherapy as a routine practice. Recent studies have shown that paclitaxel or docetaxel combined chemotherapy is selected because of its better antitumor effect and favorable effect for the long term prognosis.
authors.affiliation: Dept. of Obstetrics and Gynecology, Jikei University, School of Medicine, Tokyo, Japan.
authors.forename: K
authors.initials: K
authors.lastname: Ochiai
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001761:Bleomycin / Q000008:administration & dosage; D002945:Cisplatin / Q000008:administration & dosage; D019317:Evidence-Based Medicine; D005260:Female; D005472:Fluorouracil / Q000008:administration & dosage; D006801:Humans; D007069:Ifosfamide / Q000008:administration & dosage; D016685:Mitomycin / Q000008:administration & dosage; D010051:Ovarian Neoplasms / Q000188:drug therapy*; D016019:Survival Analysis; D016896:Treatment Outcome; D002583:Uterine Cervical Neoplasms / Q000188:drug therapy; D014594:Uterine Neoplasms / Q000188:drug therapy*; D014750:Vincristine / Q000008:administration & dosage
chemical_list: D001761:Bleomycin; D016685:Mitomycin; D014750:Vincristine; D002945:Cisplatin; D005472:Fluorouracil; D007069:Ifosfamide